FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
219713NDANUVATION001IBTROZICAPSULE;ORALEQ 200MG BASETALETRECTINIB ADIPATE2025-06-11PrescriptionYes